Bayer relaunches antifungal brand Canesten in India
For over 40 years, Canesten has been helping people around the world to treat and prevent skin and foot infections
The consumer health division of Bayer has launched the new and improved range of Canesten, their anti-fungal treatment solution in India. Available in powder and cream formats, the product range offers anti-fungal properties that help to prevent and treat skin infections. An easy-to-use solution, Canesten is a full-cycle skin infection control formulation that not only provides relief from itching, but also halts the spread of infection, Bayer notified in a statement.
Based on Bayer’s original research molecule Clotrimazole, the Canesten range brings the required relief as it treats a wide spectrum of fungal skin infections, the statement added.
Available in 110 countries, the relaunch of Canesten in India highlights Bayer’s commitment to focus on bringing science-based solutions.
Talking about the launch, Sandeep Verma, Country Head, Bayer Consumer Health, India, said in the statement, “As we focus on strengthening our dermatology portfolio in India, we are determined to take the legacy of Bayer’s original research molecule Clotrimazole to new heights and establish Canesten as the go-to solution for skin infection in women.”
Canesten dusting powder is available as 50g and 100g SKUs (Stock Keeping Units) while Canesten cream is available in a 30g tube – all of which can be purchased as an OTC product across India. The other two SKUs, Canesten S cream in 15 gm tube and Canesten V6 tablets can be purchased with a doctor’s prescription, the statement concluded.
- Advertisement -